与通常治疗相比,对亨廷顿病基因扩张载体 (GUIDE-HD) 的焦虑指导自助:一个随机对照可行性试验
Maria Dale1, Fiona J R Eccles2, Katie Melvin1
1Leicestershire Partnership NHS Trust, Mill Lodge, Narborough, Leicestershire, LE19 4SL, Leicester, UK.
Pilot and feasibility studies
|September 12, 2023
概括
这项研究评估了对亨廷顿病 (HD) 基因载体的焦虑指导自助疗法. 结果将决定这种干预是否可用于更大的试验,旨在改善患有HD的人的生活质量.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 遗传学 是一个遗传学.
背景情况:
- 亨廷顿病 (HD) 是一种神经退行性疾病,影响认知,运动技能和情绪健康.
- 焦虑在HD基因携带者中普遍存在 (高达71%),显著影响生活质量并增加自杀风险.
- 证据支持在其他神经退行性疾病中使用谈话疗法治疗焦虑,但不是专门用于HD.
研究的目的:
- 进行针对HD基因扩张携带者的焦虑指导自助心理干预的可行性研究.
- 评估研究设计和干预对未来大规模随机对照试验的可行性.
主要方法:
- 一项探索性随机控制可行性研究,将指导自助 ("GUIDE-HD") 与通常治疗 (TAU) 相比较.
- GUIDE-HD干预集成了认知行为疗法 (CBT) 和接受和承诺疗法 (ACT),适应了HD.
- 15个HD基因扩张载体被分配给每组,数据在干预前和后的多个时间点收集.
主要成果:
- 可行性将通过招聘和保留率,干预坚持以及干预和措施的可接受性来评估.
- 将分析定量和定性数据,以告知更大的试验设计.
- 利益相关者的意见,包括来自HD患者和护理人员的意见,是干预开发的组成部分.
结论:
- 这项研究对于评估一种新型的HD患者焦虑干预措施的可行性至关重要.
- 积极的可行性结果可能会为一项更大的试验铺平道路,以确定治疗疗效.
- 干预的发展优先考虑利益相关者需要提高可接受性和潜在的有效性.
相关概念视频
01:30Generalized Anxiety Disorder
155
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
155
01:18Anxiety: Overview
299
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
299
01:28Social Anxiety Disorder
50
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
50
01:22Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
01:28Human Genetics
610
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
610
01:24Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295